Basalog
Biocon Ltd - 5 ml
Standard delivery
Distributor inventory
Insulin glargine 100 IU/mL (3 mL prefilled pen/cartridge; total 300 IU)
Management of diabetes mellitus to improve glycaemic control in adults and children where basal (long-acting) insulin is required; Type 1 diabetes (with short/rapid-acting insulin) and Type 2 diabetes (alone or with oral antidiabetics/other insulin).
Insulin glargine is a long-acting basal insulin analogue. After subcutaneous injection it forms microprecipitates that slowly release insulin, providing a relatively constant glucose-lowering effect over ~24 hours by increasing peripheral glucose uptake and reducing hepatic glucose production.
For subcutaneous use only. Inject once daily at the same time each day into abdomen, thigh or upper arm; rotate injection sites. Use as prescribed based on blood glucose; do not dilute or mix with other insulins in the same syringe/pen. Check label and appearance before use; never inject intravenously.
Common side effects of Basalog 100 may include:
Biocon Ltd - 5 ml
Standard delivery
Biocon Ltd - 1 S
Standard delivery
Biocon Ltd - 5 X3 ml
Standard delivery
Biocon Ltd - drop - 15 ml
Standard delivery
Biocon Ltd - syrup - 200 ml
Standard delivery
Biocon Ltd - tablet - 10 S
Standard delivery

Biocon Ltd - tablet - 10 S
Standard delivery
Biocon Ltd - tablet - 10 S
Standard delivery
Risk of hypoglycaemia—monitor blood glucose, especially when changing dose, meal pattern, activity or other medicines. Do not use during episodes of hypoglycaemia. Use caution in renal/hepatic impairment, elderly, and those with hypoglycaemia unawareness. Rotate injection sites to reduce lipodystrophy. Do not share pens/needles to prevent infection transmission. Seek urgent care for severe hypoglycaemia, allergic reactions, or signs of infection.